Three years ago, Kim Kardashian caused a ruckus when she touted a morning-sickness pill to her millions of followers on social media. Her posts failed to include any risk information, prompting regulators in the U.S. and Canada to issue stern warnings.

Nonetheless, the gambit paid off handsomely. The faux pas, which was subsequently corrected, generated even more publicity for the Diclegis pill, and by the fall of 2015, sales jumped 21 percent to nearly $41.7 million, according to data from IQVIA, a market research firm.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • This is not exactly news. It does not look as if these writers here are paying attention. Perhaps looking at this reality stars deceptive Pharma peddling is a safe topic. This same tactic has been used very successfully by Pharma marketers, with journalists, content marketers, patient groups, and “Influencers.” These tactics are even more effective for misleading public. Pharma ads are non stop on TV Radio, and Social Media. Along with the misleading over-hyped claims they are sending messages to the public that the industry does not need regulation, that we should forget how much money the taxpayers have invested in these so called “breakthroughs.” The American public does not have accuses to any data that would indicate whether any of this is dangerous, since only Pharma funded research is allowed. In Fact any legitimate scientific tests of any of these claims would be met with career destroying lawsuits, threats, and removal of funding. In Post Fact America as long as there is a profit, even the deaths go uncounted.

    • Hi Mavis,

      Thanks for your note.

      And I agree that celebrity endorsements are hardly new. I’ve been tracking pharma for 23 years and have seen my share.

      What is new being able to read the contract itself, confirming the kind of payments that drug makers sometimes make and, in this case, to Kim Kardashian.

      Hope this helps,
      ed

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy